IDEAS AND REALITY IN THE DEVELOPMENT OF CANCER CHEMOTHERAPEUTIC-AGENTS, WITH PARTICULAR REFERENCE TO OXAZAPHOSPHORINE CYTOSTATICS

被引：17

作者：

BROCK, N

机构：

来源：

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1986年 / 111卷 / 01期

关键词：

D O I：

10.1007/BF00402768

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1 / 12

页数：12

共 56 条

[31]

HOHORST HJ, 1976, CANCER TREAT REP, V60, P309

[32]

HOHORST HJ, 1986, ADV ENZYME REGULATIO

[33]

ISHIDATE M, 1953, Gan, V44, P342

[34] HIGH-DOSE IFOSFAMIDE AND MESNA AS CONTINUOUS INFUSION OVER 5 DAYS - A PHASE-I PHASE-II TRIAL [J].

KLEIN, HO ;

WICKRAMANAYAKE, PD ;

COERPER, C ;

CHRISTIAN, E ;

POHL, J ;

BROCK, N .

CANCER TREATMENT REVIEWS, 1983, 10 :167-173

[35]

KLEIN HO, 1982, 13TH INT CANC C SEAT

[36]

KOHN FR, 1984, P AM ASS CANCER RES, V25, P689

[37]

LARIONOV LF, 1965, CANCER CHEMOTHERAPY

[38] AN EXAMINATION OF THE RELATIVE RESISTANCES TO AFLATOXIN-B1 AND SUSCEPTIBILITIES TO GAMMA-GLUTAMYL-TRANSFERASE PARA-PHENYLENE DIAMINE MUSTARD OF GAMMA-GLUTAMYL-TRANSFERASE TRANSFERASE NEGATIVE AND POSITIVE CELL-LINES [J].

MANSON, MM ;

LEGG, RF ;

WATSON, JV ;

GREEN, JA ;

NEAL, GE .

CARCINOGENESIS, 1981, 2 (07) :661-670

[39]

NORPOTH KA, 1977, P INT HOL S DUSS GER, P40

[40]

Popper Karl, 1982, LOGIK FORSCHUNG

← 1 2 3 4 5 6 →